Every day, millions of people across the globe are being diagnosed with one form of cancer or another. Though there are numerous therapies for cancer, especially for the ones caught in its earlier stages, their effects on the body is sometimes as taxing as the cancer itself.
Chemotherapeutic drugs are often effective because they are cell killers. They kill cancer cells along with the healthy fast growing cells of the body. Wouldn’t it be wonderful to have a type of cancer therapy which would not make the individual with cancer a walking ad for cancer?
The Vitamin C Breakthrough
The University of Kansas conducted a research what uses Intravenous Vitamin C together with conventional chemotherapy, and the results of their study is astounding.
In the University of Kansas study, a group of 27 patients who were all newly diagnosed with ovarian cancer (stage 3 or stage 4) were given high doses of intravenous vitamin C together with their conventional chemotherapy of carboplatin or paclitaxel. They found out that the vitamin C therapy did not only kill cancer cells but also greatly reduced the toxic effects of the chemotherapy drugs.
In another study conducted on rodents, an intravenous infusion of vitamin C was used and they found out that it was able to kill cancer cells with no noticeable pathological changes in the spleen, kidney or liver and no toxicity.
During the 70s, vitamin C was used by alternative and complementary medicine physicians as an unorthodox form of cancer treatment and it was unaccepted by conventional medicine practitioners who were unconvinced of its therapeutic benefits. All of this is changing now because of the findings of recent researches about the topic which are really exciting.
This study, which was published in Science Translational Medicine aims to pin point the cellular actions that causes pharmacologic vitamin C has as a form of therapy for cancer.
Researcher Dr. Jeanne Drisko, who is the director of the integrative medicine program at the University of Kansas Medical Center states that through the study, they now have a better understanding of how vitamin C acts against cancer cells. She also states that they now know the clear safety profile of vitamin C and the clinical and biological likelihood together with a firm base on how to proceed. She further states that altogether, their data provides a strong evidence that will justify bigger clinical trials to truly examine how beneficial is the addition of vitamin C to conventional chemotherapy.
Cancer cells typically multiply rapidly. This is why conventional chemotherapy agents are usually drugs which kills fast growing cells. However, there are other fast growing cells on the human body, such as the lining of the gut, and these cells are also killed when using conventional cancer therapies, hence, the typical cancer patient who is receiving conventional chemo manifests toxic effects from these medications such as vomiting, a weakened immune system and falling off of the hair.
With the use of intravenous vitamin C, these side effects from using conventional chemotherapeutic agents can be reduced if not altogether eliminated. Now, that’s certainly good news!